![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Kaku S. Yano S. Kawasaki T. Sakai Y. Suzuki K.-i. Kawamura K. Masuho Y. Satoh N. Takenaka T. Landolfi N.F. Man S.C.
Publisher: Elsevier
ISSN: 0306-3623
Source: General Pharmacology, Vol.27, Iss.3, 1996-04, pp. : 435-439
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Kaku S. Kawasaki T. Sakai Y. Taniuchi Y. Yano S. Suzuki K.-i. Terazaki C. Kawamura K. Masuho Y. Satoh N. Takenaka T. Yanagi K. Ohshima N.
European Journal of Pharmacology, Vol. 279, Iss. 2, 1995-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fab Antibody Fragments: Some Applications in Clinical Toxicology
By Robert J. Flanagan Alison L. Jones
Drug Safety, Vol. 27, Iss. 14, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Vugmeyster Yulia Szklut Pam Wensel David Ross John Xu Xin Awwad Michel Gill Davinder Tchistiakov Lioudmila Warner Garvin
Pharmaceutical Research, Vol. 28, Iss. 7, 2011-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antiplatelet Therapies: Platelet GPIIb / IIIa Antagonists and Beyond
Current Pharmaceutical Design, Vol. 9, Iss. 28, 2003-11 ,pp. :